![]() |
|
|
1 Department of Pharmacology, University of Illinois College of Medicine, Chicago
N-(2-bromoethyl)-N-ethyl-l-naphthalenemethylamine·HBr and N-2-(2-biphenylyloxy)ethyl-N-(2-chloroethyl)butylamine·HCl, in relatively small doses of 1.0 and 5.0 mgm./kgm., intravenously, respectively, have been shown to be active adrenergic blocking compounds by virtue of the ability to reverse the action of epinephrine and to diminish or block the pressor responses to anoxia, carotid occlusion, and small doses of nicotine in dogs. The experimental evidence supports a peripheral adrenergic blocking action.
Submitted on August 2, 1948